TDP-43与神经退行性疾病及脑损伤的相关性研究进展

蔡斌; 宋海; 王振; 韩雪; 于建云

TDP-43与神经退行性疾病及脑损伤的相关性研究进展

蔡斌¹,
宋海^1,2,
王振¹,
韩雪¹,
于建云¹

1. 昆明医科大学法医学院
2. 昆明医科大学第一附属医院神经外科

基金项目:

基金：国家自然科学基金资助项目 (81360467); 云南省科技厅-昆明医科大学应用基础研究联合专项基金资助项目 (2013FB104);

计量
- 文章访问数: 1598
- HTML全文浏览量: 578
- PDF下载量: 173
- 被引次数: 0
出版历程
- 收稿日期: 2017-09-10

Research Progress of the Relationship of the Expression of TAR DNA/RNA-binding Domain Protein 43 in Neurodegenerative Disease and Brain Injury

Cai Bin ¹,
Song Hai ^1,2,
Wang Zhen ¹,
Han Xue ¹,
Yu Jian Yun ¹

Funds:

基金：国家自然科学基金资助项目 (81360467); 云南省科技厅-昆明医科大学应用基础研究联合专项基金资助项目 (2013FB104);

摘要

摘要: TAR DNA/RNA结合蛋白43 (TARDNA/RNA-binding domain protein 43, TDP-43) 是一种高度保守、广泛表达的核蛋白.肌萎缩侧索硬化症 (amyotrophic lateral sclerosis, ALS) 、额颞叶变性 (frontotemporal lobar degeneration, FTLD) 、阿尔茨海默病 (alzheimer disease, AD) 等神经退行性疾病的病理学标记蛋白被公认是TDP-43.就TDP-43的结构、功能及其与神经退行性疾病之间的关系作一综述.同时在对TDP-43生物学特性认识的基础上, 探讨TDP-43在急、慢性颅脑损伤中的特殊表达与作用, 从而探索TDP-43在法医病理学中确定死亡原因、判定致伤致残情况的可行性.
- TDP-43 /
- 神经退行性疾病 /
- 法医病理学 /
- 脑损伤
Abstract: TAR DNA/RNA-binding domain protein 43 (TDP-43) is a highly conserved and widely expressed nuclear protein. TDP-43 is recognized as a pathological marker protein of amyotrophic lateral sclerosis (ALS) , frontotemporal lobar degeneration (FTLD) and alzheimer disease (AD) .This article discusses the structure and the function of TDP-43 and the relationship of its expression in neurodegenerative disease.Meanwhile, this article emphatically probes into the specific expression andfunction of TDP-43 in acute and chronic brain injury based on the knowledge of its biological characteristics, aiming to explore the feasibility for determining the cause of death and the injury and disability situations by TDP-43 in forensic pathology.
- TDP-43 /
- Neurodegenerative disease /
- Forensic pathology /
- Brain injuries

HTML全文

参考文献(24)

[1]	[1]NEUMANN M, SAMPATHU D M, KWONG L K, et al.Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amy-otrophic lateral sclerosis[J].Science, 2006, 314 (5796) :130-133.
[2]	[2]JOSEPHS K A, MURRAY M E, WHITWELL J L, et al.Staging TDP-43 pathology in Alzheimer’s disease[J].Acta Neuropathol, 2014, 127 (3) :441-450.
[3]	[3]BURATTI E, BARALLE F E.Multiple roles of TDP-43 in gene expression, splicing regulation, and human disease[J].Front Biosci, 2008, (13) :867-878.
[4]	[4]ZHANG Y J, XU Y F, COOK C, et al.Aberrant cleavage of TDP-43 enhances aggregation and cellular toxicity[J].Proc Natl Acad Sci U S A, 2009, 106 (18) :7607-7612.
[5]	[5]AYALA Y M, MISTELI T, BARALLE FE.TDP-43regulates retinoblastoma protein phosphorylation through the repression of cyclin-dependent kinase 6 expression[J].Proc Natl Acad Sci USA, 2008, 105 (10) :3785-3789.
[6]	[6]FIESEL F C, VOIGT A, WEBER S S, et al.Knockdown of transactive response DNA-binding protein (TDP-43) downregulates histone deacetylase 6[J].EMBO J, 2010, 29 (1) :209-221.
[7]石磊, 叶城辉, 何若洁.肌萎缩侧索硬化症基因TDP-43致病突变对斑马鱼毒性的影响[J].中山大学学报, 2014, 35 (4) :481-487.
[8]	[8]PHOEBE S, TSOI D R, KYOUNG-JAE CHOI, et al.The N-terminal domain of ALS-linked TDP-43 assembles without Misfolding[J].Angewandte Chemie International Edition, 2017, 56 (47) :12590-12593.
[9]赵嘉玲, 樊东升.外周组织中的TDP-43蛋白病理及其临床诊断价值研究进展[J].北京医学, 2016, 38 (5) :474-477.
[10]	[10]MACKENZIE I R, BABORIE A, PICKERING-BROWN S, et al.Het-erogeneity of ubiquitin pathology in frontotemporal lobardegeneration:classification and relation to clinical phenotype[J].Acta Neuropathol, 2006, 112 (5) :539-549.
[11]	[11]DAVIDSON Y, KELLEY T, MACKENZIE I R, et al.Ubiq-uitinated pathological lesions in frontotemporal lobardegeneration contain the TAR DNA-binding protein, TDP-43[J].Acta Neuropathol, 2007, 113 (5) :521-533.
[12]	[12]RACHEL H, TAN, JILLIAN J, et al.TDP-43 proteinopathies:pathological identification of brain regions differentiating clinical phenotypes[J].Brain, 2015, 138, (5) :3110-3122,
[13]	[13]EMMA L, SCOTTER, HAN-JOU CHEN, et al.TDP-43proteinopathy and ALS:insights into disease mechanisms and therapeutic targets, Neurotherapeutics[J].April, 2015, 12 (2) :352-363.
[14]	[14]EMMA L, SCOTTER, CAROLINE VANCE, et al.Differential roles of the ubiquitin proteasome system and autophagy in the clearance of soluble and aggregated TDP-43 species[J].Journal of Cell Science, 2014, 127 (6) :1263-1278.
[15]	[15]URYU K, NAKASHIMA-YASUDA H, FORMAN M S, et al.Concomitant TAR-DNA-binding protein 43 pathology is present in Alzheimer disease and corticobasal degenerationbut not in other tauopathies[J].J Neuropathol Exp Neurol, 2008, 67 (6) :555-564.
[16]	[16]DUYCKAERTS C, DELATOUR B, POTIER MC.Classification and basic pathology of Alzheimer disease[J].Acta Neuropathol, 2009, 118 (1) :5-36.
[17]	[17]KEITH A JOSEPHS, DENNIS W DICKSON, et al.Rates of hippocampal atrophy and presence of post-mortem TDP-43 in patients with Alzheimer's disease:a longitudinal retrospective study[J].The Lancet Neurology, 2017, 16 (11) :917-924.
[18]	[18]KEITH A, JOSEPHS, DENNIS W, et al.TDP-43 drives faster rates of hippocampal atrophy in Alzheimer’s disease starting at least 10 years prior to death[J].Alzheimer’s and Denmentia, 2017, 13 (7) :1553-1562.
[19]彭敏.创伤性脑外伤大鼠海马中TDP-43及PGRN蛋白表达的研究[D].长沙:中南大学硕士论文, 2013.
[20]	[20]BRANDON PETER LUCKE-WOLD, RYAN CODDINGTON TURNER, ARIC FLINT LOGSDON, et al.Linking traumatic brain injury to chronic traumatic encephalopathy:Identification of potential mechanisms leading to neurofibrillary tangle development[J].Journal of Neurotrauma, 2014, 31 (13) :1129-1138.
[21]	[21]KIMBRA KENNEY, DIEGO IACONO, BRIAN L EDLOW, et al.Dementia after moderate-severe traumatic brain injury:Coexistence of multiple proteinopathies[J].Journal of Neuropathology&Experimental Neurology, 2018, 77 (1) :50-63,
[22]	[22]JESSICA N, SAYKALLY, WHITNEY A, et al.Repetitive mild closed head injury alters protein expression and dendritic complexity in a mouse model[J].Journal of Neurotrauma[J].January, 2018, 35 (1) :139-148.
[23]	[23]ALAN I, FADEN, DAVID J, et al.Chronic Neurodegeneration after traumatic brain injury:Alzheimer disease, chronic traumatic encephalopathy, or persistent neuroinflammation[J].Neurotherapeutics, 2015, 12 (1) :143-150.
[24]张睿, 郑永江, 蔡斌.迷迭香干预三重脑震荡大鼠焦虑行为变化[J].昆明医科大学学报, 2017, 38 (8) :11-15.

相关文章(20)

[1]	曹艳, 蒋鸿雁, 王艳雪, 吴抖威, 钱传云, 吴海鹰, 李坪. 右美托咪定抑制大鼠创伤性脑损伤后神经细胞凋亡, 昆明医科大学学报. doi: 10.12259/j.issn.2095-610X.S20210202
[2]	熊鑫, 杨启琨, 刘凯, 瞿勇强, 雷普平, 王尚文, 李玉华. RGS17在冠状动脉粥样硬化中的表达, 昆明医科大学学报.
[3]	孙欣, 李国萍, 陈绍春. SFPQ的相关研究进展, 昆明医科大学学报.
[4]	瞿鹏飞, 李玉华, 熊鑫, 贾彭林, 孙仲春, 瞿勇强, 雷普平. 基于网络平台的法医病理学案例教学对法医学专业学生批判性思维能力的影响, 昆明医科大学学报.
[5]	虞涛. 肺部实质性占位病变110例影像学及病理学诊断的准确性, 昆明医科大学学报.
[6]	范寿成. 重型颅脑损伤患者围术期神经功能与红细胞免疫指标的变化, 昆明医科大学学报.
[7]	黄璞. FUS/TLS在基因表达调控中的作用及与神经退行性疾病的关系, 昆明医科大学学报.
[8]	黄万麒. 交通事故中机械性损伤与自身疾病关系的法医学鉴定1例报道, 昆明医科大学学报.
[9]	张劲松. 根治性膀胱癌标本中肿瘤侵犯前列腺及精囊的病理学研究, 昆明医科大学学报.
[10]	李璠. 单核细胞趋化蛋白-1和血管内皮生长因子mRNA在急性甲醇中毒大鼠脑组织的表达, 昆明医科大学学报.
[11]	张利蕊. 孕产妇死亡案例的法医病理学分析, 昆明医科大学学报.
[12]	钱忠义. 猴实验性肺螨感染的病理学观察, 昆明医科大学学报.
[13]	闵晓红. 结肠腺癌伴神经内分泌分化的临床病理学意义, 昆明医科大学学报.
[14]	陆鹏. 围产儿死亡医疗纠纷案例的法医病理学鉴定分析, 昆明医科大学学报.
[15]	周虹. 皮肤基底细胞癌178例临床特征及组织病理学分析, 昆明医科大学学报.
[16]	刘巨鹏. 病毒性脑炎15例法医病理学分析及其临床意义, 昆明医科大学学报.
[17]	段艳萍. GAP-43治疗大鼠完全性脊髓损伤后Nogo-A在神经元的表达, 昆明医科大学学报.
[18]	. 重型颅脑损伤的护理体会, 昆明医科大学学报.
[19]	. 高频超声在上肢外周神经损伤性疾病的应用价值, 昆明医科大学学报.
[20]	. 甲状腺疾病猝死10例分析, 昆明医科大学学报.